Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Ambrx Biopharma Inc. | 389,000 | reported | 05 Jul 2023 | tx 2+2,989,000 |
| ONCOLYTICS BIOTECH INC | 55,100 | reported | 11 Feb 2026 | tx 1+29,600 |
| Ambrx Biopharma, Inc. | 0 | reported | 07 Mar 2024 | tx 4+100,000−526,998 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Feb 2026 | PURCHASE | ONCOLYTICS BIOTECH INC | 29,600 | 0.86 USD | |
| 07 Mar 2024 | OTHER | Ambrx Biopharma, Inc. | 55,570 | — | deriv |
| 07 Mar 2024 | OTHER | Ambrx Biopharma, Inc. | 100,000 | — | deriv |
| 07 Mar 2024 | OTHER | Ambrx Biopharma, Inc. | 371,428 | — | deriv |
| 11 Dec 2023 | GRANT_AWARD | Ambrx Biopharma, Inc. | 100,000 | 0.00 USD | |
| 05 Jul 2023 | GRANT_AWARD | Ambrx Biopharma Inc. | 389,000 | 0.00 USD | deriv |
| 28 Apr 2023 | GRANT_AWARD | Ambrx Biopharma Inc. | 2,600,000 | 0.00 USD | deriv |